EUVIMEDEUVIMED entdecken
Open Access

ACSL6-activated IL-18R1–NF-κB promotes IL-18–mediated tumor immune evasion and tumor progression

Yuqin Di iD, Ziyang Wang iD, Jing Xiao iD, Xiang Zhang iD, Lvlan Ye iD, Xiangqiong Wen iD, Jiale Qin iD, Ligong Lu iD, Xiongjun Wang iD, Weiling He iD

Science Advances · 2024

DOI: 10.1126/sciadv.adp0719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Yuqin Di und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China. Hauptthemen laut MEDLINE: Coenzyme A Ligases, Interleukin-18, NF-kappa B. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant activation of IL-18 signaling regulates tumor immune evasion and progression. However, the underlying mechanism remains unclear. Here, we report that long-chain acyl-CoA synthase 6 (ACSL6) is highly expressed in liver cancer and correlated with poor prognosis. ACSL6 promotes tumor growth, metastasis, and immune evasion mediated by IL-18, independent of its metabolic enzyme activity. Mechanistically, upon IL-18 stimulation, ACSL6 is phosphorylated by ERK2 at S674 and recruits IL-18RAP to interact with IL-18R1, thereby reinforcing the IL-18R1–IL-18RAP heterodimer and triggering NF-κB–dependent gene expression to facilitate tumor development. Furthermore, the up-regulation of CXCL1 and CXCL5 by ACSL6 promotes tumor-associated neutrophil and tumor-associated macrophage recruitment, thereby inhibiting cytotoxic CD8 + T cell infiltration. Ablation or S674A mutation of ACSL6 potentiated anti–PD-1 therapeutic efficacy by increasing the effector activity of intertumoral CD8 + T cells. We revealed that ACSL6 is a potential adaptor that activates IL-18–NF-κB axis–mediated tumor immune evasion and provides valuable insights for developing effective immunotherapy strategies for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coenzyme A LigasesInterleukin-18NF-kappa BAnimalsFemaleHumansMiceCD8-Positive T-LymphocytesCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticLiver NeoplasmsNeoplasmsPhosphorylationReceptors, Interleukin-18Signal TransductionTumor EscapeLong-Chain-Fatty-Acid-CoA LigaseInterleukin-18 Receptor alpha Subunit

Substanzen

Coenzyme A LigasesInterleukin-18NF-kappa BReceptors, Interleukin-18Long-Chain-Fatty-Acid-CoA LigaseIL18 protein, humanIL18R1 protein, humanInterleukin-18 Receptor alpha SubunitACSL6 protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), Zhuhai, Guangdong 519000, China.
  • Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • School of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China.
  • Department of Gastrointestinal Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361000, China.

ORCID-Profile: Yuqin Di, Ziyang Wang, Jing Xiao, Xiang Zhang, Lvlan Ye, Xiangqiong Wen, Jiale Qin, Ligong Lu, Xiongjun Wang, Weiling He

Zitieren

APA

Di, Y., Wang, Z., Xiao, J., Zhang, X., Ye, L., Wen, X., Qin, J., Lu, L., Wang, X., & He, W. (2024). ACSL6-activated IL-18R1–NF-κB promotes IL-18–mediated tumor immune evasion and tumor progression. Science Advances. https://doi.org/10.1126/sciadv.adp0719

Vancouver

Di Y, Wang Z, Xiao J, Zhang X, Ye L, Wen X, et al. ACSL6-activated IL-18R1–NF-κB promotes IL-18–mediated tumor immune evasion and tumor progression. Science Advances. 2024. doi:10.1126/sciadv.adp0719

BibTeX
@article{Di2024,
  author = {Di, Yuqin and Wang, Ziyang and Xiao, Jing and Zhang, Xiang and Ye, Lvlan and Wen, Xiangqiong and Qin, Jiale and Lu, Ligong and Wang, Xiongjun and He, Weiling},
  title = {ACSL6-activated IL-18R1–NF-κB promotes IL-18–mediated tumor immune evasion and tumor progression},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adp0719}
}
Kostenlos starten →